Global Human Prothrombin Complex Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
According to our (Global Info Research) latest study, the global Human Prothrombin Complex market size was valued at USD 1622.7 million in 2022 and is forecast to a readjusted size of USD 3431.5 million by 2029 with a CAGR of 11.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent. 
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report is a detailed and comprehensive analysis for global Human Prothrombin Complex market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Prothrombin Complex market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (M USD/Unit), 2018-2029
Global Human Prothrombin Complex market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (M USD/Unit), 2018-2029
Global Human Prothrombin Complex market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (M USD/Unit), 2018-2029
Global Human Prothrombin Complex market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (M USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Prothrombin Complex
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Prothrombin Complex market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma and Hualan Biological and  etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Prothrombin Complex market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    500 IU/Vial
    600 IU/Vial
    1000 IU/Vial
    Others
Market segment by Application
    Hemophilia B
    Vitamin K Deficiency
    Others
Major players covered
    Takeda
    CSL
    Grifols
    Octapharma
    Hualan Biological
    Meheco Xinxing Pharma
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Prothrombin Complex product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Prothrombin Complex, with price, sales, revenue and global market share of Human Prothrombin Complex from 2018 to 2023.
Chapter 3, the Human Prothrombin Complex competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Prothrombin Complex breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Prothrombin Complex market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Prothrombin Complex.
Chapter 14 and 15, to describe Human Prothrombin Complex sales channel, distributors, customers, research findings and conclusion.